Pure Encapsulations Inc

Alkermes is a worldwide pharmaceutical company that develops controlled, sustained-release injectable drugs using with its trademark ProLease and Medisorb technologies. Located in Massachusetts, the company also develops inhaled formulations from its proprietary pulmonary technology. Alkermes has partnered with Johnson & Johnson to develop Riserpdal Consta, an antipsychotic drug used in the treatment of schizophrenia. Risperdal Consta is approved for sale in more than 50 countries that include the United States, United Kingdom and Germany. In addition to a host of partnered products, the ocmpany is also active in the development of several promising proprietary products, such as Vivitrex, a long-acting injectable form of naltrexone for alcohol dependence. Alkermes is headquartered in Cambridge, Mass.

Morphic Holding, Inc is a cutting-edge technology company based in Waltham, MA, specializing in innovative solutions for various industries. With a focus on research and development, Morphic Holding, Inc is dedicated to pushing the boundaries of what is possible in the world of technology. Generated from their business information

Parexel International, based in Newton, MA, is a leading Contract Research Organization (CRO) offering end-to-end solutions in biotech and therapeutic expertise for the development of life-changing medicines. With a focus on patient impact, Parexel provides services ranging from portfolio optimization and regulatory strategy to phase I-IV clinical trials and market access planning. The company's diverse capabilities include portfolio management, early development and innovation, integrated clinical development, approval and access, value substantiation, and lifecycle management. Parexel's global reach, operational excellence, and commitment to leveraging cutting-edge technologies make them a trusted partner in advancing healthcare and improving patient outcomes. Generated from the website